Statement of the DOG, the RG, and the BVA on the therapeutic use of voretigene neparvovec (Luxturna TM) in ophthalmology (January 2019)
PDF
Springer Link
Recommendations by the DOG for the planning of clinical trials on behalf of third parties (March 2018)
PDF
Springer Link
Statement of the Professional Association of German Ophthalmologists (BVA), the German Society of Ophthalmology (DOG) and the German Retina Society (RG) on central serous chorioretinopathy (January 2018) PDF
Springer Link
Statement of the BVA, the DOG, and the RG on treatment of choroidal neovascularization in diseases other than neovascular age-related macular Degeneration (October 2017)
PDF
Springer Link
Statement and supplementary statement from the BVA, the DOG, and the RG on laser treatment of drusen in age-related macular Degeneration (AMD) (August 2017, update October 2018)
PDF
Springer Link
Statement of the DOG and BVA on Transorbital alternating current stimulation in optic neuropathy (December 2016)
PDF
